From: Super-enhancers complexes zoom in transcription in cancer
Target | Small-molecule inhibitor | Disease | Status | Phase | NCT number | |
---|---|---|---|---|---|---|
TF | KLF5 | SR18662 | Colorectal Cancer [221] | –- | –- | –- |
ML264 | Colorectal Cancer [221] | –- | –- | –- | ||
Breast Cancer [222] | –- | –- | –- | |||
TCF4 | LF3 | Colon Cancer [223] | –- | –- | –- | |
MYC | MYCi361 | Prostate Cancer [224] | –- | –- | –- | |
MYCi975 | Glioma [117] | –- | –- | –- | ||
EN4 | Breast Cancer [225] | –- | –- | –- | ||
HMEs | HDAC3 | Hepatocellular Carcinoma [226] | –- | –- | –- | |
HDAC1, HDAC2, HDAC3 | Domatinostat (4SC-202) | Merkel Cell Carcinoma [227] | –- | –- | –- | |
Advanced Hematologic Malignancies | Completed | 1 | ||||
Non Small Cell Lung Cancer | Recruiting | 2 | ||||
Cervical Cancer | Recruiting | 1/2 | ||||
PCI-24781 | Lymphoma Follicular | Recruiting | 2 | |||
Metastatic Solid Tumors | Recruiting | 1 | ||||
Sarcoma | Completed | 1/2 | ||||
Largazole | Colorectal Cancer [228] | –- | –- | –- | ||
HDAC1, HDAC3, HDAC7 | MS-275 (Entinostat) | Melanoma | Recruiting | 2 | NCT03765229 | |
Breast Cancer | Recruiting | 1 | NCT03473639 | |||
MGCD0103 | Rhabdomyosarcoma | Recruiting | 1 | |||
Urothelial Carcinoma | Completed | 2 | ||||
Vorinostat | Non-small Cell Lung Cancer | Terminated | 1/2 | |||
Lymphoma | Completed | 3 | NCT01728805 | |||
Multiple Myeloma | Completed | 1/2 | NCT01502085 | |||
Panobinostat | Mesothelioma | Completed | 1 | NCT00535951 | ||
Non Small Cell Lung Cancer | Completed | 1 | NCT00535951 | |||
JMJD2A | Z-JIB-04 | Breast Cancer [229] | –- | –- | –- | |
KDM6A | GSK J1 | Glioblastoma [230] | –- | –- | –- | |
Neck Squamous Cell Carcinoma [231] | –- | –- | –- | |||
EP300 | CPI-637 | Prostate Cancer [232] | –- | –- | –- | |
Y08197 | Prostate Cancer [232] | –- | –- | –- | ||
Cofactors | BRD4 | AZD5153 | Malignant Solid Tumor | Completed | 1 | NCT03205176 |
Lymphadenoma | Completed | 1 | NCT03205176 | |||
ABBV-075 | Prostate Cancer | Completed | 1 | NCT02391480 | ||
Breast Cancer | Completed | 1 | NCT02391480 | |||
Multiple Myeloma | Completed | 1 | NCT02391480 | |||
BMS-986158 | Advanced Cancer | Completed | 1/2 | NCT02419417 | ||
Solid Tumor Childhood | Recruiting | 1 | ||||
Lymphoma | Recruiting | 1 | ||||
Brain Tumor | Recruiting | 1 | ||||
CPI-0610 | Myelofifibrosis | Recruiting | 2 | NCT02158858 | ||
PLX51107 | Sarcoma | Terminated | 2 | NCT02683395 | ||
Breast Cancer | Terminated | 2 | NCT02683395 | |||
Uveal Melanoma | Terminated | 2 | NCT02683395 | |||
INCB054329 | Ovarian Cancer | Terminated | 1/2 | NCT02431260 | ||
Lymphoma | Terminated | 1/2 | NCT02431260 | |||
FT-1101 | Acute myeloid leukemia | Completed | 1 | NCT02543879 | ||
iBET151 | Gastric cancer [233] | –- | –- | –- | ||
JQ1 | Prostate Cancer [234] | –- | –- | –- | ||
Ovarian Cancer [235] | –- | –- | –- | |||
Multiple Myeloma Cells [236] | –- | –- | –- | |||
BRD2, BRD4 | CC-90010 | Glioblastoma | Recruiting | 1 | ||
Astrocytoma | Active not recruiting | 1 | ||||
BRD2, BRD3, BRD4 | GSK525762 | NUT Carcinoma | –- | 1 | NCT01597703 | |
OTX-015 | Acute Leukemia | Completed | 1 | NCT01713582 | ||
Lymphoma | Completed | 1 | NCT01713582 | |||
NUT Midline Carcinoma | Completed | 1 | NCT02259114 | |||
Adenocarcinoma | Completed | 1 | NCT02259114 | |||
Triple Negative Breast Cancer | Completed | 1 | NCT02259114 | |||
BRDT, BRD2, BRD3, BRD4 | ODM-207 | CRPC | –- | 1 | NCT03035591 | |
Melanoma | –- | 1 | NCT03035591 | |||
Non-Medullary Carcinoma | –- | 1 | NCT03035591 | |||
Cofactors | CDK7 | SY-1365 | Ovarian Cancer | Recruiting | 1 | NCT03134638 |
Breast Cancer | Recruiting | 1 | NCT03134638 | |||
CT7001 | Advanced Solid Malignancies | Recruiting | 2 | NCT03363893 | ||
THZ1 | Neuroblastoma [40] | –- | –- | –- | ||
Glioma [237] | –- | –- | –- | |||
CDK9 | Dinaciclib | Hepatocellular carcinoma [238] | –- | –- | –- | |
Acute Myeloid Leukemia | Active not recruiting | 1 | ||||
Malignant Solid Neoplasm | Recruiting | 1 | ||||
Lung Epithelial Cancer [239] | –- | –- | –- | |||
Hepatocellular Carcinoma [240] | –- | –- | –- | |||
BAY 1143572 | Leukemia | Completed | 1 | |||
Neoplasms | Completed | 1 | ||||
CDK4, CDK6 | Trilaciclib | Small cell lung cancer | Completed | 1/2 | NCT02499770 | |
PD-0332991 | Lung cancer | Recruiting | 1 | NCT03170206 | ||
Metastatic Pancreatic Ductal Adenocarcinoma | Completed | 1 | NCT02501902 | |||
Ribociclib (LEE011) | Non-small cell lung cancer | Completed | 1 | NCT02292550 | ||
Breast Cancer | Recruiting | 4 | ||||
Ovarian Carcinoma | Recruiting | 1 | ||||
SPH3643 | Colon Cancer [241] | –- | –- | –- | ||
Glioblastoma [241] | –- | –- | –- | |||
CDK12, CDK13 | THZ531 | Prostate Cancer [242] | –- | –- | –- | |
CDK8, CDK19 | BCD-115 | Breast Cancer | Completed | 1 | NCT03065010 |